ACTRN12622001172796
Not yet recruiting
未知
Investigating the impact of a community pharmacy-based service on medication management amongst home-dwelling people living with dementia: a pilot study
niversity of New South Wales (UNSW)0 sites25 target enrollmentAugust 29, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of New South Wales (UNSW)
- Enrollment
- 25
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Consumers with mild cognitive impairment, diagnosed or suspected dementia and home dwelling in the Perth metropolitan area. The inclusion criteria is also extended to the family carer if appropriate.
- •Pharmacists are to be community pharmacists with access to current Medscheck services in the Perth metropolitan area. The pharmacists will be currently registered to practise with the Australian Health Practitioner Regulation Agency.
Exclusion Criteria
- •Pharmacists working only from aged care or hospitals are excluded from the study. Pharmacists outside of the Perth Metropolitan area or interstate will not be eligible for the study.
- •Consumers no longer able to provide consent due to their cognitive impairment. Consumers currently residing in an aged care facility will be excluded from the study. Consumers residing outside of the Perth Metropolitan area or interstate will not be eligible for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviewsadverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)NL-OMON28732Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands200
Not yet recruiting
Not Applicable
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000049814ational Hospital Organization Mie Chuo Medical Center40
Recruiting
Not Applicable
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease ProjectACTRN12609000705280Monash450
Active, not recruiting
Not Applicable
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA
Active, not recruiting
Not Applicable
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by headache and/or fever in the setting of a common coldMedical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjects with early (= 48 hours) cold symptoms of blocked nose with headache and/or fever.EUCTR2004-001637-41-BEPfizer Consumer Healthcare cva/sca